Table 2.

Survival and perioperative outcomes: P/D.

Author/year	Survival median	Disease-free survival	Mortality	Morbidity	Hospital stay	Comments
Schipper et al., 2008 [20]	Total P/D 17.2 months Subtotal P/D 8.1 months	TP, 1 year, 80%; 2 years 35% ST, 1 year, 30%; 2 years, 15%; 3 years, 3.7%	2.9%	2 + 2 subtotal (20 + 5.9%)	6.5 days (median)	Total or subtotal pleurectomy groups
Luckraz et al., 2010 [21]	26 months	55%, 2 years	1.1%	13%	unknown
Flores et al., 2008 [22]	23 months	12% at 5 years	4%	6.4% (respiratory only reported)	unknown
Okada et al., 2008 [23]	17	24%, 3 years	0%	unknown	unknown
Nakas et al., 2008 [26]	15.3 R 7.1 NR	66%, 54%, 33%, and 16.3% at 1, 2, 3, and 4 years; R—45%, 16%, 4%, and 0%, NR	5.9 R—9.8% NR	55% R—28% NR	unknown	Unsuitable for EPP
Aziz et al., 2002 [15]	14	45% at 1 year; 0% at 3 years	0%	unknown	unknown
Martin-Ucar et al., 2001 [27]	7.2	31% at 1 year	7.8%	9.8%	7	Target was symptom relief
Lang-Lazdunski et al., 2011 [28]	24	91.7% at 1 year; 61% at 2 years	0%	25%	unknown	TMT plus hyperthermic pleural lavage
Lang-Lazdunski et al., 2012 [24]	12.8	49% at 2 years; 30.1% at 5 years	0%	27.7%	unknown
Rena and Casadio 2012 [25]	23 stage II 32 stage I	stage I: two years and 3 years, 67% and 44% stage II: 49% and 9%	0%	24%	7	QoL